Abstract

The insulin/insulin-like growth factor signalling axis is an evolutionary ancient and highly conserved hormonal system involved in the regulation of metabolism, growth and lifespan in animals. Human insulin is stored in the pancreas, while insulin-like growth factor-1 (IGF-1) is maintained in blood in complexes with IGF-binding proteins (IGFBP1–6). Insect insulin-like polypeptide binding proteins (IBPs) have been considered as IGFBP-like structural and functional homologues. Here, we report structures of the Drosophila IBP Imp-L2 in its free form and bound to Drosophila insulin-like peptide 5 and human IGF-1. Imp-L2 contains two immunoglobulin-like fold domains and its architecture is unrelated to human IGFBPs, suggesting a distinct strategy for bioavailability regulation of insulin-like hormones. Similar hormone binding modes may exist in other insect vectors, as the IBP sequences are highly conserved. Therefore, these findings may open research routes towards a rational interference of transmission of diseases such as malaria, dengue and yellow fevers.

Details

Title
Structures of insect Imp-L2 suggest an alternative strategy for regulating the bioavailability of insulin-like hormones
Author
Roed, Nikolaj Kulahin 1   VIAFID ORCID Logo  ; Viola, Cristina M 2 ; Kristensen, Ole 3   VIAFID ORCID Logo  ; Schluckebier, Gerd 1   VIAFID ORCID Logo  ; Norrman, Mathias 1 ; Sajid, Waseem 1 ; Wade, John D 4   VIAFID ORCID Logo  ; Andersen, Asser Sloth 1   VIAFID ORCID Logo  ; Kristensen, Claus 5   VIAFID ORCID Logo  ; Ganderton, Timothy R 2 ; Turkenburg, Johan P 2   VIAFID ORCID Logo  ; De Meyts, Pierre 6   VIAFID ORCID Logo  ; Brzozowski, Andrzej M 2   VIAFID ORCID Logo 

 Global Research, Novo Nordisk A/S, Maaloev, Denmark 
 York Structural Biology Laboratory, Department of Chemistry, The University of York, Heslington, York, UK 
 Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen Ø, Denmark 
 Florey Institute of Neuroscience & Mental Health, University of Melbourne, Parkville, VIC, Australia; School of Chemistry, University of Melbourne, Parkville, VIC, Australia 
 Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen N, Denmark 
 Global Research, Novo Nordisk A/S, Maaloev, Denmark; Department of Cell Signalling, de Duve Institute, Brussels, Belgium 
Pages
1-12
Publication year
2018
Publication date
Sep 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2110818767
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.